Css LLC Cure Vac N.V. Transaction History

Css LLC

$928 Million
Q3 2025

A detailed history of Css LLC transactions in Cure Vac N.V. stock. As of the latest transaction made, Css LLC holds 273,495 shares of CVAC stock, worth $1.44 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares

273,495

Holding current value

$1.44 Million

% of portfolio

0.16%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2025 Nov 13, 2025	BUY	$5.34 - $5.51 $1.46 Million - $1.51 Million	273,495 New	273,495 $1.47 Million
Q2 2021 Aug 16, 2021	BUY	$56.91 - $127.53 $269,639 - $604,237	4,738 New	4,738 $348,000

Others Institutions Holding CVAC

# of Institutions

108

Shares Held

22.5M

Call Options Held

124K

Put Options Held

77.1K

Glazer Capital, LLC New York, NY

4.55M
Shares

$24 Million
0.82% of portfolio
Alpine Associates Management Inc. Englewood Cliffs, NJ

2.3M
Shares

$12.1 Million
0.78% of portfolio
Black Rock Inc. New York, NY

2.25M
Shares

$11.9 Million
0.0% of portfolio
Qube Research & Technologies LTD London, X0

1.71M
Shares

$9.04 Million
0.01% of portfolio
Bill & Melinda Gates Foundation Seattle, WA

1.57M
Shares

$8.28 Million
10.6% of portfolio

View Full List

About CureVac N.V.

Ticker CVAC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,467,008
Market Cap $990M
Description
CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...

More about CVAC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

News

Stay updated on Css LLC with notifications on news.

Account